133 related articles for article (PubMed ID: 36484486)
1. Depletion of circPDSS1 inhibits ITGA11 production to confer cisplatin sensitivity through miR-515-5p in gastric cancer.
Wang Y; Tang S; Li L; Sun C; Liu Y; Zhao Y
J Chemother; 2023 Oct; 35(6):514-526. PubMed ID: 36484486
[TBL] [Abstract][Full Text] [Related]
2. Circ_0007841 knockdown confers cisplatin sensitivity to ovarian cancer cells by down-regulation of NFIB expression in a miR-532-5p-dependent manner.
Gao Y; Huang Y
J Chemother; 2023 Apr; 35(2):117-130. PubMed ID: 35380509
[TBL] [Abstract][Full Text] [Related]
3. Circular RNA circVAPA promotes chemotherapy drug resistance in gastric cancer progression by regulating miR-125b-5p/STAT3 axis.
Deng P; Sun M; Zhao WY; Hou B; Li K; Zhang T; Gu F
World J Gastroenterol; 2021 Feb; 27(6):487-500. PubMed ID: 33642823
[TBL] [Abstract][Full Text] [Related]
4. Exosome-Derived Circ-PVT1 Contributes to Cisplatin Resistance by Regulating Autophagy, Invasion, and Apoptosis Via miR-30a-5p/YAP1 Axis in Gastric Cancer Cells.
Yao W; Guo P; Mu Q; Wang Y
Cancer Biother Radiopharm; 2021 May; 36(4):347-359. PubMed ID: 32799541
[No Abstract] [Full Text] [Related]
5. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis.
Feng N; Guo Z; Wu X; Tian Y; Li Y; Geng Y; Yu Y
Respir Res; 2021 Sep; 22(1):248. PubMed ID: 34537072
[TBL] [Abstract][Full Text] [Related]
6. Long Noncoding RNA Plasmacytoma Variant Translocation 1 Regulates Cisplatin Resistance via miR-3619-5p/TBL1XR1 Axis in Gastric Cancer.
Wu C; Hu Y; Ning Y; Zhao A; Zhang G; Yan L
Cancer Biother Radiopharm; 2020 Dec; 35(10):741-752. PubMed ID: 32407172
[No Abstract] [Full Text] [Related]
7. Hsa_circ_0017639 regulates cisplatin resistance and tumor growth via acting as a miR-1296-5p molecular sponge and modulating sine oculis homeobox 1 expression in non-small cell lung cancer.
Chang F; Li J; Sun Q; Wei S; Song Y
Bioengineered; 2022 Apr; 13(4):8806-8822. PubMed ID: 35287543
[TBL] [Abstract][Full Text] [Related]
8. Linc00852 from cisplatin-resistant gastric cancer cell-derived exosomes regulates COMMD7 to promote cisplatin resistance of recipient cells through microRNA-514a-5p.
Cao S; Fu B; Cai J; Zhang D; Wang C; Wu H
Cell Biol Toxicol; 2023 Apr; 39(2):483-496. PubMed ID: 35088190
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA circ_0005667 promotes cisplatin resistance of endometrial carcinoma cells by regulating IGF2BP1 through miR-145-5p.
Sun G; Tian J; Xiao Y; Zeng Y
Anticancer Drugs; 2023 Aug; 34(7):816-826. PubMed ID: 36728962
[TBL] [Abstract][Full Text] [Related]
10. CircRNA circPDSS1 promotes the gastric cancer progression by sponging miR-186-5p and modulating NEK2.
Ouyang Y; Li Y; Huang Y; Li X; Zhu Y; Long Y; Wang Y; Guo X; Gong K
J Cell Physiol; 2019 Jul; 234(7):10458-10469. PubMed ID: 30417526
[TBL] [Abstract][Full Text] [Related]
11. LncRNA SNHG6 knockdown inhibits cisplatin resistance and progression of gastric cancer through miR-1297/BCL-2 axis.
Mei J; Liu G; Li R; Xiao P; Yang D; Bai H; Hao Y
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34821362
[TBL] [Abstract][Full Text] [Related]
12. Circ_0010235 confers cisplatin resistance in lung cancer by upregulating E2F7 through absorbing miR-379-5p.
Wang L; Wang D; Xu Z; Qiu Y; Chen G; Tan F
Thorac Cancer; 2023 Jul; 14(20):1946-1957. PubMed ID: 37277864
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of cir_RNA PVT1 Elevates Gastric Cancer Cisplatin Sensitivity via Sponging miR-152-3p.
Wang X; Zhang Y; Li W; Liu X
J Surg Res; 2021 May; 261():185-195. PubMed ID: 33444948
[TBL] [Abstract][Full Text] [Related]
14. Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis.
Xie H; Yao J; Wang Y; Ni B
Drug Deliv; 2022 Dec; 29(1):1257-1271. PubMed ID: 35467477
[TBL] [Abstract][Full Text] [Related]
15. MiR-200c-3p and miR-485-5p overexpression elevates cisplatin sensitivity and suppresses the malignant phenotypes of non-small cell lung cancer cells through targeting RRM2.
Liu Y; Zhang Y; Li Q; Xu R; Huang N
Thorac Cancer; 2022 Jul; 13(13):1974-1985. PubMed ID: 35599447
[TBL] [Abstract][Full Text] [Related]
16. Circ_0048856 competes with ABCC1 for miR-193a-5p/miR-98-5p binding sites to promote the cisplatin resistance and tumorigenesis in lung cancer.
Liu L; Zhang Q; Peng H
J Chemother; 2023 Feb; 35(1):39-52. PubMed ID: 35289739
[TBL] [Abstract][Full Text] [Related]
17. circ-LDLRAD3 Knockdown Reduces Cisplatin Chemoresistance and Inhibits the Development of Gastric Cancer with Cisplatin Resistance through miR-588 Enrichment-Mediated SOX5 Inhibition.
Liang Q; Chu F; Zhang L; Jiang Y; Li L; Wu H
Gut Liver; 2023 May; 17(3):389-403. PubMed ID: 35975639
[TBL] [Abstract][Full Text] [Related]
18. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X
Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110
[TBL] [Abstract][Full Text] [Related]
19. miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs).
Liu X; Zhou X; Chen Y; Huang Y; He J; Luo H
Neoplasma; 2020 Jan; 67(1):147-157. PubMed ID: 31686523
[TBL] [Abstract][Full Text] [Related]
20. MiR-874-3p represses the migration and invasion yet promotes the apoptosis and cisplatin sensitivity via being sponged by long intergenic non-coding RNA 00922 (LINC00922) and targeting Glycerophosphodiester Phosphodiesterase Domain Containing 5 (GDPD5) in gastric cancer cells.
Zhang X; Dai X; Zhao X; Wang J; Dou J; Zhuang H; Chen N; Zhao H
Bioengineered; 2022 Mar; 13(3):7082-7104. PubMed ID: 35282764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
